125 related articles for article (PubMed ID: 31393283)
1. Intratumor Heterogeneity of KIT Gene Mutations in Acral Lentiginous Melanoma.
Comodo-Navarro AN; Fernandes M; Barcelos D; Carapeto FCL; Guimarães DP; de Sousa Moraes L; Cerutti J; Iwamura ESM; Landman G
Am J Dermatopathol; 2020 Apr; 42(4):265-271. PubMed ID: 31393283
[TBL] [Abstract][Full Text] [Related]
2. Acral Lentiginous Melanomas Harbour Intratumor Heterogeneity in BRAF Exon 15, With Mutations Distinct From V600E/V600K.
Fernandes M; Barcelos D; Comodo AN; Guimarães DP; Lopes Carapeto FC; Cardili L; de Sousa Morães L; Cerutti Ap J; Landman Ap G
Am J Dermatopathol; 2019 Oct; 41(10):733-740. PubMed ID: 31021835
[TBL] [Abstract][Full Text] [Related]
3. Correlation between KIT expression and KIT mutation in melanoma: a study of 173 cases with emphasis on the acral-lentiginous/mucosal type.
Torres-Cabala CA; Wang WL; Trent J; Yang D; Chen S; Galbincea J; Kim KB; Woodman S; Davies M; Plaza JA; Nash JW; Prieto VG; Lazar AJ; Ivan D
Mod Pathol; 2009 Nov; 22(11):1446-56. PubMed ID: 19718013
[TBL] [Abstract][Full Text] [Related]
4. KIT, NRAS, BRAF and PTEN mutations in a sample of Swedish patients with acral lentiginous melanoma.
Zebary A; Omholt K; Vassilaki I; Höiom V; Lindén D; Viberg L; Kanter-Lewensohn L; Johansson CH; Hansson J
J Dermatol Sci; 2013 Dec; 72(3):284-9. PubMed ID: 23993026
[TBL] [Abstract][Full Text] [Related]
5. Molecular profiling, including TERT promoter mutations, of acral lentiginous melanomas.
Vazquez Vde L; Vicente AL; Carloni A; Berardinelli G; Soares P; Scapulatempo C; Martinho O; Reis RM
Melanoma Res; 2016 Apr; 26(2):93-9. PubMed ID: 26709572
[TBL] [Abstract][Full Text] [Related]
6. BRAF, KIT and NRAS mutations and expression of c-KIT, phosphorylated extracellular signal-regulated kinase and phosphorylated AKT in Japanese melanoma patients.
Oyama S; Funasaka Y; Watanabe A; Takizawa T; Kawana S; Saeki H
J Dermatol; 2015 May; 42(5):477-84. PubMed ID: 25766129
[TBL] [Abstract][Full Text] [Related]
7. Analysis of KIT expression and gene mutation in human acral melanoma: with a comparison between primary tumors and corresponding metastases/recurrences.
Dai B; Cai X; Kong YY; Yang F; Shen XX; Wang LW; Kong JC
Hum Pathol; 2013 Aug; 44(8):1472-8. PubMed ID: 23528861
[TBL] [Abstract][Full Text] [Related]
8. Distribution and clinical role of KIT gene mutations in melanoma according to subtype: a study of 492 Spanish patients.
Millán-Esteban D; García-Casado Z; Manrique-Silva E; Virós A; Kumar R; Furney S; López-Guerrero JA; Requena C; Bañuls J; Traves V; Nagore E
Eur J Dermatol; 2021 Dec; 31(6):830-838. PubMed ID: 33648909
[TBL] [Abstract][Full Text] [Related]
9. KIT gene mutations and patterns of protein expression in mucosal and acral melanoma.
Abu-Abed S; Pennell N; Petrella T; Wright F; Seth A; Hanna W
J Cutan Med Surg; 2012; 16(2):135-42. PubMed ID: 22513068
[TBL] [Abstract][Full Text] [Related]
10. The clinical significance of KIT mutations in melanoma: a meta-analysis.
Gong HZ; Zheng HY; Li J
Melanoma Res; 2018 Aug; 28(4):259-270. PubMed ID: 29746316
[TBL] [Abstract][Full Text] [Related]
11. Mutations in KIT occur at low frequency in melanomas arising from anatomical sites associated with chronic and intermittent sun exposure.
Handolias D; Salemi R; Murray W; Tan A; Liu W; Viros A; Dobrovic A; Kelly J; McArthur GA
Pigment Cell Melanoma Res; 2010 Apr; 23(2):210-5. PubMed ID: 20088873
[TBL] [Abstract][Full Text] [Related]
12. BRAF, KIT, NRAS, GNAQ and GNA11 mutation analysis in cutaneous melanomas in Turkish population.
Yilmaz I; Gamsizkan M; Kucukodaci Z; Berber U; Demirel D; Haholu A; Narli G
Indian J Pathol Microbiol; 2015; 58(3):279-84. PubMed ID: 26275246
[TBL] [Abstract][Full Text] [Related]
13. Large-scale analysis of KIT aberrations in Chinese patients with melanoma.
Kong Y; Si L; Zhu Y; Xu X; Corless CL; Flaherty KT; Li L; Li H; Sheng X; Cui C; Chi Z; Li S; Han M; Mao L; Lu A; Guo J
Clin Cancer Res; 2011 Apr; 17(7):1684-91. PubMed ID: 21325067
[TBL] [Abstract][Full Text] [Related]
14. Melanoma hyperpigmentation is strongly associated with KIT alterations.
Wu JM; Alvarez H; García P; Rojas PL; Wong G; Maitra A; Antonescu C; Montgomery EA
Am J Dermatopathol; 2009 Oct; 31(7):619-25. PubMed ID: 19652585
[TBL] [Abstract][Full Text] [Related]
15. Novel somatic Missense Mutations in Exon 11 of the KIT Gene are Detected in Melanoma.
Palkina N; Tyumentseva A; Ruksha T
Asian Pac J Cancer Prev; 2023 Sep; 24(9):3015-3020. PubMed ID: 37774052
[TBL] [Abstract][Full Text] [Related]
16. KIT gene mutations and copy number in melanoma subtypes.
Beadling C; Jacobson-Dunlop E; Hodi FS; Le C; Warrick A; Patterson J; Town A; Harlow A; Cruz F; Azar S; Rubin BP; Muller S; West R; Heinrich MC; Corless CL
Clin Cancer Res; 2008 Nov; 14(21):6821-8. PubMed ID: 18980976
[TBL] [Abstract][Full Text] [Related]
17. [ Spectrum of oncogene mutations is different in melanoma subtypes].
Mazurenko NN; Tsyganova IV; Lushnikova AA; Ponkratova DA; Anurova OA; Cheremushkin EA; Mikhailova IN; Demidov LV
Mol Biol (Mosk); 2015; 49(6):1022-9. PubMed ID: 26710785
[TBL] [Abstract][Full Text] [Related]
18. Novel somatic KIT exon 8 mutation with dramatic response to imatinib in a patient with mucosal melanoma: a case report.
Rapisuwon S; Parks K; Al-Refaie W; Atkins MB
Melanoma Res; 2014 Oct; 24(5):509-11. PubMed ID: 25003536
[TBL] [Abstract][Full Text] [Related]
19. Sinonasal, genital and acrolentiginous melanomas show distinct characteristics of KIT expression and mutations.
Schoenewolf NL; Bull C; Belloni B; Holzmann D; Tonolla S; Lang R; Mihic-Probst D; Andres C; Dummer R
Eur J Cancer; 2012 Aug; 48(12):1842-52. PubMed ID: 22464346
[TBL] [Abstract][Full Text] [Related]
20. c-Kit inhibitors for unresectable or metastatic mucosal, acral or chronically sun-damaged melanoma: a systematic review and one-arm meta-analysis.
Steeb T; Wessely A; Petzold A; Kohl C; Erdmann M; Berking C; Heppt MV
Eur J Cancer; 2021 Nov; 157():348-357. PubMed ID: 34562816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
